Editorial Board

Biography

Prof. George Perry

College of Sciences, University of Texas at San Antonio, USA


Email: [email protected]


Qualifications

1979     Ph.D., University of California at San Diego, USA, Marine Biology

1974     B.Sc., University of California at Santa Barbara, USA, Zoology


Publications (Selected)


  1. Reddy VP, Beyaz A, Perry G, Cooke MS, Sayre LM, Smith MA. The role of oxidative damage to nucleic acids in the pathogenesis of neurological disease. In: Oxidative Damage to Nucleic Acids, Evans MD, Cooke MS, Eds, Landes Bioscience and Springer Science+Business,Austin,Texas,Philadelphia,Pennsylvania, 2007, pp 123-140.
  2. Castellani R, Lee H-g, Perry G, Smith MA, Zhu X. Comment: Amyloid spin doctors. Alzheimer Research Forum, 2007, http://www.alzforum.org/pap/annotation.asp?powID=66848.
  3. Zhu X, Su B, Wang X, Smith MA, Perry G. Causes of oxidative stress in Alzheimer disease. Cell Mol Life Sci 64:2202-2210, 2007.(73)
  4. Bryan K, Casadesus G, Perry G, Smith MA. Comment: Estrogen and Alzheimer disease: is it really all in the timing? Alzheimer Research Forum, 2007, http://www.alzforum.org/pap/annotation.asp?powID=69747.
  5. Castellani RJ, Moreira PI, Liu G, Dobson J, Perry G, Smith MA, Zhu X. Iron: the redox-active center of oxidative stress in Alzheimer disease. Neurochem Res 32:1640-1645, 2007.(33)
  6. Webber KM, Perry G, Smith MA, Casadesus G. The contribution of luteinizing hormone to Alzheimer disease pathogenesis. Clin Med Res 5:177-183, 2007.
  7. Castellani RJ, Lee H-g, Zhu X, Nunomura A, Perry G, Smith MA. Alzheimer’s disease: pathology vs etiology. Int J Neuroprot Neuroregen 4:36-40, 2007.
  8. Nunomura A, Moreira PI, Takeda A, Smith MA, Perry G. Oxidative RNA damage and neurodegeneration. Curr Med Chem 14:2968-2975, 2007.(24)
  9. Perry G, Zhu X, Lee H-g, Smith MA. Alzheimer disease, the oxidative hypothesis. 2007 Conference Proceedings of the 58th Annual Meeting of the American College of Veterinary Pathologists/42nd Annual Meeting of the American Society for Veterinary Clinical Pathology, pp 374-377, 2007.
  10. Moreira PI, Siedlak SL, Wang X, Santos MS, Oliveira CR, Tabaton M, Nunomura A, Szweda LI, Aliev G, Smith MA, Zhu X, Perry G. Increased autophagic degradation of mitochondria in Alzheimer disease. Autophagy 3:614-615, 2007.(22)
  11. Castellani RJ, Perry G, Smith MA. The role of novel chitin-like polysaccharides in Alzheimer disease. Neurotox Res 12:269-274, 2007.(2)
  12. Nunomura A, Moreira PI, Lee HG, Zhu X, Castellani RJ, Smith MA, Perry G. Neuronal death and survival under oxidative stress in Alzheimer and Parkinson diseases. CNS Neurol Disord Drug Target 6:411-423, 2007.
  13. Webber KM, Casadesus G, Bowen RL, Perry G, Smith MA. Evidence for the role of luteinizing hormone in Alzheimer disease. Endocr Metab Immune Disord Drug Targets 7:300-303, 2007.
  14. Wang X, Su B, Perry G, Smith MA, Zhu X. Insights into amyloid-β-induced mitochondrial dysfunction in Alzheimer disease. Free Radic Biol Med 43:1569-1573, 2007.(27)
  15. Aliev G, Cobb CJ, Pacheco G, Shenk JC, Moreira PI, Morales LA, Fischbach K, Gasimov E, Perry G. The role of oxidative stress and vasoactive substances in the pathophysiology of Alzheimer’s disease. In: Biomarkers for Early Diagnosis of Alzheimer’s Disease, Galimberti D, Scarpini E, Eds, Nova Science Publishers Inc., Hauppauge, New York, 2008, pp 241-263.
  16. Moreira PI, Smith MA, Zhu X, Nunomura A, Perry G. The potential application of antioxidant agents in Alzheimer disease therapeutics. In: Pharmacological Mechanisms in Alzheimer’s Therapeutics, Cuello AC, Ed, Springer Press, New York, New York, 2008, pp 194-211.
  17. Nunomura A, Moreira PI, Zhu X, Cash AD, Smith MA, Perry G. Role of oxidative insult and neuronal survival in Alzheimer’s and Parkinson’s diseases. In: Advances in Alzheimer’s and Parkinson’s Diseases, Fisher A, Hanin I, Memo M, Stocchi F, Eds, Springer Press, New York, New York, 2008, pp 133-148.(1)
  18. Zhu X, Perry G, Smith MA. Two hits and you’re out? A novel mechanistic hypothesis of Alzheimer disease. In: Advances in Alzheimer’s and Parkinson’s Diseases, Fisher A, Hanin I, Memo M, Stocchi F, Eds, Springer Press, New York, New York, 2008, pp 191-204.(4)
  19. Zhu X, Casadesus G, Webber KM, Atwood CS, Bowen RL, Perry G, Smith MA. Parallels between neurodevelopment and neurodegeneration: a case study of Alzheimer’s disease. In: Handbook of Neurochemistry and Molecular Neurobiology: Developmental and Aging Changes in the Nervous System, Perez-Polo JR, Rossner S, Eds, Springer Science+Business Media, LLC, Philadelphia, Pennsylvania, 2008, pp 147-155.
  20. Sayre LM, Perry G, Smith MA. Oxidative stress and neurotoxicity. Chem Res Tox 21:172-188, 2008.(91)
  21. Perry G, Castellani RJ, Moreira PI, Lee H-g, Zhu X, Smith MA. Pathology's new role: defining disease process and protective responses. Int J Clin Exp Pathol 1:1-4, 2008.
  22. Moreira PI, Santos MS, Oliveira CR, Shenk JC, Nunomura A, Smith MA, Zhu X, Perry G. Alzheimer disease and the role of free radicals in the pathogenesis of the disease. CNS Neurol Disord Drug Targets 7:3-10, 2008.(37)
  23. Casadesus G, Rolston RK, Webber KM, Atwood CS, Bowen RL, Perry G, Smith MA. Menopause, estrogen, and gonadotropins in Alzheimer’s disease. Adv Clin Chem 45:139-153, 2008.